Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 86 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Evobrutinib for treating relapsing multiple sclerosis	Evobrutinib	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Eszopiclone for treating insomnia	Eszopiclone	Insomnia	Neurology	2024	View \| Download
Eptinezumab for prevention of Migraine	Eptinezumab (ALD403)	Migraine	Neurology	2020	View \| Download
Efgartigimod PH20 SC for treating chronic inflammatory demyelinating polyradiculoneuropathy	Efgartigimod PH20 SC	Chronic inflammatory demyelinating polyradiculoneuropathy	Neurology	2023	View \| Download
Edaravone for treating amyotrophic lateral sclerosis	Edaravone oral (FNP1222)	Amyotrophic lateral sclerosis	Neurology	2023	View \| Download
Edaravone for amyotrophic lateral sclerosis	Edaravone (IV) (Radicava; MCI-186; Radicut; Edaravone)	Motor neurone disease (MND or ALS)	Neurology	2018	View \| Download
Dronabinol for muscle spasticity caused by multiple sclerosis	Dronabinol (BX-1; PPP-002; Syndros; Namisol; ECP002A)	Muscle spasticity	Musculoskeletal System , Neurology	2021	View \| Download
Donanemab for treating early symptomatic Alzheimer's disease	Donanemab	Alzheimer's disease	Neurology	2022	View \| Download
Diroximel fumarate for relapsing-remitting multiple sclerosis	Diroximel fumarate (BIIB098; ALKS-8700)	Multiple sclerosis (MS)	Neurology	2019	View
Dimethyl fumarate for relapsing remitting multiple sclerosis in people aged 13 years and older	Dimethyl fumarate (FP-187)	Multiple sclerosis (MS)	Neurology	2022	View \| Download